Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
about
Hormone therapy for sexual function in perimenopausal and postmenopausal womenAssociation of Mid-Life Changes in Body Size, Body Composition and Obesity Status with the Menopausal TransitionOsteoporosis and obesity: Role of Wnt pathway in human and murine modelsGC-TOF/MS-based metabolomic profiling of estrogen deficiency-induced obesity in ovariectomized rats.Estrogen suppresses adipogenesis by inhibiting S100A16 expression.Relationship of body composition with prevalence of osteoporosis in central south Chinese postmenopausal women.Effect of St. John's Wort (Hypericum perforatum) on obesity, lipid metabolism and uterine epithelial proliferation in ovariectomized ratsEstrogen replacement and skeletal muscle: mechanisms and population health.Managing sarcopenia and its related-fractures to improve quality of life in geriatric populations.Effect of hormone therapy on lean body mass, falls, and fractures: 6-year results from the Women's Health Initiative hormone trials.Mathematically derived body volume and risk of musculoskeletal pain among housewives in North India.Is obesity in women protective against osteoporosis?Similarities in acquired factors related to postmenopausal osteoporosis and sarcopenia.The "love hormone" oxytocin regulates the loss and gain of the fat-bone relationshipBody composition and muscle performance during menopause and hormone replacement therapy.Anabolic hormones in aging women: effects of supplementation vs. physical activity.Relationship of obesity with osteoporosis.Association of 11β-hydroxysteroid dehydrogenase type I expression and activity with estrogen receptor β in adipose tissue from postmenopausal women.Analysis of the effects of oestrogen receptor alpha (ERalpha)- and ERbeta-selective ligands given in combination to ovariectomized ratsThe role of estrogens in control of energy balance and glucose homeostasis.Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosisManipulation of Ovarian Function Significantly Influenced Sarcopenia in Postreproductive-Age Mice.Influence of hormone replacement therapy on eccentric exercise induced myogenic gene expression in postmenopausal women.An ERβ agonist induces browning of subcutaneous abdominal fat pad in obese female mice.Associations between gender, age and waist circumference.Menopause, estrogens and frailty.Treatment of body composition changes in obese and overweight older adults: insight into the phenotype of sarcopenic obesity.Prevention of diseases after menopause.Adipose, bone and muscle tissues as new endocrine organs: role of reciprocal regulation for osteoporosis and obesity development.Hormones, herbal preparations and nutriceuticals for a better life after the menopause: part I.Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome.Study of oleanolic acid on the estrodiol production and the fat production of mouse preadipocyte 3T3-L1 in vitro.Amelioration of estrogen-deficiency-induced obesity by Ocimum gratissimum.Relation of body fat distribution to femoral neck bone density and endometrial thickness in postmenopausal women.Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.Ankle stiffness in postmenopausal women: influence of hormone therapy and menopause nature.Effect of the timing of weight cycling during adulthood on mortality risk in overweight and obese postmenopausal women.Serum Sex Hormones, IGF-1, and IGFBP3 Exert a Sexually Dimorphic Effect on Lean Body Mass in Aging.Anti-osteopenic effect of alpha-ketoglutarate sodium salt in ovariectomized rats.Point:Counterpoint: Estrogen and sex do/do not influence post-exercise indexes of muscle damage, inflammation, and repair.
P2860
Q24202201-861A7056-1425-44E5-95D3-F4D9695CCBD3Q26740255-2CA72C33-A2FE-46CC-B4E5-7F4DCA1280F2Q27026535-B6663102-4DF9-4E14-AFF7-F3B371A0B904Q33565734-C299471E-3A1A-47DA-94C6-FE246EA5D9F9Q33709988-0D6D7D90-3B4A-4A77-B0A1-AC01DE571305Q33757720-DA2954B4-D9BE-416C-A1A5-EBD0564B5152Q33758962-8799F7D7-5CEC-4708-A100-1B4CE2A123F0Q33891395-5875A9FF-5C71-4CC4-8360-80D06AA13F03Q33962042-6054304E-6589-4C48-8981-0B4D5D685491Q34348683-05717368-FB9B-4688-A28C-BC024554F5F6Q35040400-EBD91DAC-3DFD-40F1-B5CD-F014FBDBDDBCQ35115117-DEF5F99A-9C58-433D-9139-68D9C1EA3CB7Q35195120-54334E71-1F1F-4466-97D0-D220B90C44BAQ35617495-A132CA38-E76C-4AB0-BDA3-3448CCC94D02Q35667577-8D8E9B89-780A-4C32-8E3A-A931934DE446Q35682938-BBDEF761-6601-443D-B6AD-E1B17048A1B7Q35792568-1A8D0A41-AEFE-467C-A29F-D98587088205Q36435450-17B2F71B-261F-4F8A-8414-9F8ED27127E7Q36734437-9C8C58DF-8EBC-42EE-ADF8-1F8A86597257Q36864744-7672AC34-DAB7-4088-84D1-E681A5A378E1Q36929029-89B04ECC-1FFF-48A3-82D8-314E7C9960BFQ37322698-99D89F9F-83E7-497B-A077-06E1A50243A1Q37422184-123382AF-11F7-43DF-A77D-53D203BDF1FEQ37475915-9DAA1724-C038-406D-AF2C-C816452124E9Q37593955-15A4E355-6D84-4B4F-A6CD-32FD443631D1Q38079268-6DA0D5D2-1640-4CF7-B231-7B72E0A74FBAQ38222204-7978F82E-C2E4-4472-AB80-45BB35439B5AQ38223587-FC068E60-D1C0-412C-B901-ED472CC82883Q38265269-98131508-A897-432C-A7EE-9EB953A34BDFQ38350761-7DE56A54-03F1-4C4C-A778-46D82E264418Q38511940-DC0C58B3-BC50-468D-84F9-FC5C35168DFDQ38975090-AFCFA1C9-8DA5-4346-9CBA-41040C2DF85EQ41455326-CB76D387-8AA4-46B5-BFE2-DAAE740ABDA6Q43154105-C179FA4C-683B-4B7C-AD21-0789B4813F78Q43256747-31D97296-0E59-427A-83ED-6E203D9CAFA3Q44278024-2124371A-9DFA-4020-810E-61C67F7EC7C5Q44324923-28E10327-54BD-4D4E-86C0-EA0479585737Q44514751-01330CC8-C461-40C0-88F9-9EF21F0DA0E2Q46290160-B1124C44-D35B-4278-A2FC-306DED80D5D0Q46503092-3425B128-B8CB-4575-9B46-C4A45657E413
P2860
Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
@en
Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
@nl
type
label
Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
@en
Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
@nl
prefLabel
Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
@en
Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
@nl
P2093
P2860
P356
P1433
P1476
Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
@en
P2093
Højgaard L
Rosenfalck AM
Sørensen MB
P2860
P304
P356
10.1038/OBY.2001.81
P577
2001-10-01T00:00:00Z